fbpx

All Clear

newpurchase_growthportfolioShares of Nu Skin (NUS) were under pressure recently because the company’s Chinese operations were (rightfully) being questioned by Chinese regulators. Now a fine has been levied and NUS is set to rise again.

I am updating my spreadsheets and will have a complete research report out shortly, but need to place buy orders now for the Growth Portfolio and Aggressive Growth Portfolio. Check back later today for a complete analysis.

Leave a Comment

Your email address will not be published. Required fields are marked *

Not a member? Sign up here for $25 a month.